[go: up one dir, main page]

ZA877900B - Active compounds for preventing tumor metastases - Google Patents

Active compounds for preventing tumor metastases

Info

Publication number
ZA877900B
ZA877900B ZA877900A ZA877900A ZA877900B ZA 877900 B ZA877900 B ZA 877900B ZA 877900 A ZA877900 A ZA 877900A ZA 877900 A ZA877900 A ZA 877900A ZA 877900 B ZA877900 B ZA 877900B
Authority
ZA
South Africa
Prior art keywords
active compounds
tumor metastases
preventing tumor
preventing
metastases
Prior art date
Application number
ZA877900A
Inventor
Werner Seitz
Seitz Werner
Lothar Daum
Daum Lothar
Franz Emling
Emling Franz
Gerhard Keilhauer
Keilhauer Gerhard
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of ZA877900B publication Critical patent/ZA877900B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The use of (+)-verapamil, (+)-gallopamil, (+)-devapamil and/or (+)-emopamil for preventing tumour metastases is described.
ZA877900A 1986-10-22 1987-10-21 Active compounds for preventing tumor metastases ZA877900B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863635931 DE3635931A1 (en) 1986-10-22 1986-10-22 ACTIVE SUBSTANCES FOR PREVENTING TUMOR METASAS

Publications (1)

Publication Number Publication Date
ZA877900B true ZA877900B (en) 1989-06-28

Family

ID=6312240

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA877900A ZA877900B (en) 1986-10-22 1987-10-21 Active compounds for preventing tumor metastases

Country Status (7)

Country Link
EP (1) EP0270782B1 (en)
JP (1) JPS63264414A (en)
AT (1) ATE79255T1 (en)
AU (1) AU607941B2 (en)
DE (2) DE3635931A1 (en)
ES (1) ES2051721T3 (en)
ZA (1) ZA877900B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3635930A1 (en) * 1986-10-22 1988-04-28 Basf Ag ACTIVE SUBSTANCES FOR TUMOR TREATMENT
DE3826796A1 (en) * 1988-08-06 1990-02-08 Basf Ag SUBSTITUTED PHENYL ACETONITRILE FOR USE AS A RESISTANCE BREAKER
DE3928287A1 (en) * 1989-08-26 1991-02-28 Knoll Ag USE OF THE (+) - ENANTIOMER OF ANIPAMIL
AU3205497A (en) * 1996-05-23 1997-12-09 G.D. Searle & Co. Pharmaceutical compositions containing non-racemic verapamil and process for optimizing the pharmaceutical activity of r- and s-verapamil
WO2002043730A1 (en) * 2000-11-29 2002-06-06 Epidauros Biotechnologie Ag Use of mdr-1 inducers for treating or preventing diseases
US20030092765A1 (en) * 2001-11-15 2003-05-15 John Kelly Treatment of abnormal increases in gastrointestinal motility with (R)-verapamil
EP3705570A1 (en) * 2014-02-10 2020-09-09 Institut Curie Use of mcoln-1 modulators to regulate cell migration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2059985C3 (en) * 1970-12-05 1979-10-04 Knoll Ag, 6700 Ludwigshafen Right-handed, basic substituted phenylacetonitriles, processes for their preparation and pharmaceuticals containing these compounds
US4690935A (en) * 1983-03-31 1987-09-01 Wayne State University Inhibition of tumor growth and metastasis with calcium channel blocker compounds
JPH0753665B2 (en) * 1984-04-20 1995-06-07 財団法人癌研究会 Anti-metastatic agent
DE3635930A1 (en) * 1986-10-22 1988-04-28 Basf Ag ACTIVE SUBSTANCES FOR TUMOR TREATMENT

Also Published As

Publication number Publication date
ATE79255T1 (en) 1992-08-15
ES2051721T3 (en) 1994-07-01
DE3635931A1 (en) 1988-04-28
JPS63264414A (en) 1988-11-01
AU7999687A (en) 1988-04-28
EP0270782A2 (en) 1988-06-15
DE3781116D1 (en) 1992-09-17
EP0270782B1 (en) 1992-08-12
EP0270782A3 (en) 1990-01-03
AU607941B2 (en) 1991-03-21

Similar Documents

Publication Publication Date Title
FI874671A (en) ANORDINATION FOR THE CONDUCT OF THE TREATMENT.
AU6800987A (en) Hyperthermic treatment of tumors
NO162238C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,4-DIHYDRO-4-OXONAFTYRIDINE INGREDIATES.
NO166080C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5,6,8-TRIFLUORKINOLINES.
NO864674D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CEFEM RELATIONS.
AU6142186A (en) Use of melatonin or related compounds for the treatment of psoriasis
EP0305890A3 (en) Use of bezafibrate for the treatment of diabetes
ZA877900B (en) Active compounds for preventing tumor metastases
IT8619378A0 (en) PROCEDURE FOR ANIONIC HOMOPOLYMERIZATION OF ALPHA-TRIFLUOROMETHYLACRYLATE.
NO165069C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CYCLOPENTYLETERS.
DE3689289D1 (en) Stabilization of polyolefins.
IL74177A (en) Stabilized enzyme conjugate composition containing a calcium salt and a polyethylene glycol
ZM7286A1 (en) Combination preparations for the treatment of malaria
AU5684086A (en) Use of an aqueous chlorite matrix solution for the treatment of tumors
AU569354B2 (en) (-)-1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane
NO863113D0 (en) PROCEDURE FOR THE PREPARATION OF HETEROCYCLOCARBONYL AND ACETYL-THIAZOLONES.
EP0401262A4 (en) 24r-scymnol, and preparation and use thereof
FI861454L (en) TEARABLE PART OF USE.
NO884635L (en) PROCEDURE FOR TREATMENT OF FEEDS.
NO862454D0 (en) PROCEDURE FOR THE TREATMENT OF PEROXYDE WHITE DISPOSAL.
FI864790A0 (en) PROCEDURE FOR FRAMSTATION OF AV 5-CHLOROCH 5-BROMO-2-HYDROXINICOTIN SYROR.
IT1245368B (en) Compound with calcium antagonistic activity
GB8616440D0 (en) Materials for treatment of tumours
SU1124506A1 (en) Working environment for electric-erosion treatment
UA7929A1 (en) 2,7-dioxyfluorenone-9 thiosemicarbazone having antiviral activity